Literature DB >> 25380355

Anticoagulant rodenticide exposure and toxicosis in coyotes (Canis latrans) in the Denver Metropolitan Area.

Sharon A Poessel1, Stewart W Breck, Karen A Fox, Eric M Gese.   

Abstract

Anticoagulant rodenticides are widely used in urban areas to control rodent pests and are responsible for secondary poisoning in many nontarget wildlife species. We tested the livers of five coyotes (Canis latrans) in the Denver Metropolitan Area, Colorado, US, for anticoagulant rodenticides. All five livers were positive for brodifacoum, with values ranging from 95 ppb to 320 ppb, and one liver was positive for bromadiolone, with a value of 885 ppb. Both of these rodenticides are second-generation anticoagulants, which are more potent and more likely to cause secondary poisoning than first-generation anticoagulants due to their accumulation and persistence in the liver. We concluded that exposure to these rodenticides may have caused the death of at least two of the five coyotes, and urban coyotes in our study area are commonly exposed to rodenticides.

Entities:  

Keywords:  Brodifacoum; bromadiolone; poison; second-generation; toxicant; urban

Mesh:

Substances:

Year:  2015        PMID: 25380355     DOI: 10.7589/2014-04-116

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  3 in total

1.  Poor health is associated with use of anthropogenic resources in an urban carnivore.

Authors:  Maureen Murray; Mark A Edwards; Bill Abercrombie; Colleen Cassady St Clair
Journal:  Proc Biol Sci       Date:  2015-05-07       Impact factor: 5.349

2.  Urban rat exposure to anticoagulant rodenticides and zoonotic infection risk.

Authors:  Maureen H Murray; Cecilia A Sánchez
Journal:  Biol Lett       Date:  2021-08-11       Impact factor: 3.812

3.  The intrepid urban coyote: a comparison of bold and exploratory behavior in coyotes from urban and rural environments.

Authors:  Stewart W Breck; Sharon A Poessel; Peter Mahoney; Julie K Young
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.